CSF EULAR Symposium Flyer
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
THE CYTOKINE SIGNALLING FORUM PRESENTS<br />
Satellite <strong>Symposium</strong><br />
The “Case” for<br />
JAK Inhibitors<br />
Chair<br />
Elena Nikiphorou<br />
Kings College London<br />
London, UK<br />
<strong>EULAR</strong> 23<br />
Annual Congress<br />
Friday 2 June 2023<br />
17:30–18:45 CEST<br />
South Hall<br />
Space 4<br />
Peter Nash<br />
School of Medicine,<br />
Griffith University<br />
Brisbane, Australia<br />
Clinical Considerations in Initiating<br />
JAK Inhibitors in RA<br />
Treatment considerations and labelling<br />
recommendation for commencing treatment<br />
with a JAK Inhibitor in patients with RA<br />
Scenarios:<br />
– MTX-IR patient<br />
– TNF-IR patient<br />
Lorenzo Dagna<br />
Vita-Salute San<br />
Raffaele University<br />
School of Medicine<br />
Milan, Italy<br />
Clinical Consideration in Managing<br />
RA Patients on JAK Inhibitors<br />
Optimising the management of patients<br />
currently treated with JAK Inhibitors<br />
Scenarios:<br />
– Inadequate response to first JAK Inhibitor<br />
– Clinical options in adequate responders<br />
to a JAK Inhibitor<br />
Register for FREE content at<br />
www.cytokinesignalling.com<br />
THIS SYMPOSIUM IS INDEPENDENTLY PROVIDED<br />
BY THE CYTOKINE SIGNALLING FORUM AND<br />
SPONSORED BY<br />
Follow us at:<br />
Cytokine Signalling Forum<br />
DEVELOPED UNDER<br />
THE AUSPICES OF THE
Change language